Aerie(美国)

Aerie Pharmaceuticals

Aeriewww.aeriepharma.com治疗青光眼药物AeriePharmaceuticalsisaclinical-stagepharmaceuticalcompanyfocusedonthediscovery,developmentandcommercializationoffirst-in-classtherapiesforthetreatmentofpatientswithglau comaandotherdiseasesoftheeye.Aerie'sleadproductcandidate,AR-13324,isthefirstofanewdual-actiondrugclassthatwasdiscoveredbyAeriescientists.AR-13324isaonce-dailyeyedropdesignedtoreduceintraocularpressureinpatientswithglaucomaorocularhypertension.Aerie'sproductcandidatePG324isafixedcombinationofdual-actionAR-13324withlatanoprostformulatedinasingleeyedropandisdesignedtolowerintraocularpressurebyreducingfluidinflowwhilealsoopeningbothoftheeye'sfluiddrains.AerieislocatedinBedminster,NewJersey,ResearchTrianglePark,NorthCarolina,andNewportBeach,California. AeriePharmaceuticalsRichardRubino,908-470-432